Empowerment exceeds conventional boundaries. And, so do equality, and responsibility.

Women, today, share the responsibility with their partners in all fields of life. Wellness being no exception. This is one of the primary factors behind the rapid growth in the demand for female condoms globally.

Empowered through education and awareness, women today are stepping-up to take responsibility and actions in not only helping prevent unwanted childbirth, but also stop the menace of sexually transmitted diseases (STDs) and sexually transmitted infections (STIs).

Most women today, across geographies and cultures, are open to try female contraceptives and many of them, and not their partners, admitted to being the one to take the initiative to use contraceptives.

Global Female Condom Market: Insight

Perceived to be health-friendly, as they do not influence natural hormones, female contraceptives do not cause ill-effects on health, unlike pills and injection shots. They can potentially also enhance sexual foreplay between the partners wherein the woman can derive extra stimulation of clitoris on account of the condom’s external ring design. Made up of non-latex products such as nitrile and polyurethane, they are safer to use and can be purchased without a prescription across the globe, except the US.

With the sex ratio skewed toward females in various regions, including North America, Russia, Eastern Europe, and a majority of South African countries, the potential market for female condom is expanding rapidly. According to a market research report, Condom Market – Global Outlook and Forecast 2018−2023 by Arizton Advisory & Intelligence, the global female condom market is tipped to post a CAGR of 18.92% in terms of value during 2017–2023.

Global Female Condom Market: Key Vendor Analysis

The increasing demand for female contraceptives globally has seen a sudden influx of manufacturers trying to cash-in on this growing market. As of now, the female condom market has around 6–7 major manufacturers catering to the market demand.

Till now, companies such as Veru, erstwhile The Female Health Company, have been enjoying monopoly in offering female contraceptives in the US as its products FC1 and FC2 were certified and approved by the USFDA. However, with more and more  manufacturers completing the WHO prequalification process successfully and getting approved by the UNFPA, Veru is feeling the heat in the global market.

Cupid Limited, an India-based company, has been leading the competition with its female condom in the global market. The company received its prequalification by the WHO in 2012 and the clearance by the UNFPA thereafter to sell its female contraceptives worldwide.

Hindustan Latex Limited (HLL), another India-based company, has also received prequalification from the WHO and the clearance from the UNFPA in 2016 to market and sell its Velvet brand worldwide.

Another manufacturer, Shanghai Dahua Medical Apparatus Company, has been prequalified by the WHO and cleared by the UNFPA in 2016.

The female condom market is riding the “growth” wave and will continue to do so with increased demand from across geographies.

You may reach us at

Mail: enquiry@arizton.com

Call: +13124657864